 - Continuously increasing WBC count on 2 consecutive evaluations 2 weeks apart with the final assessment showing a doubling of WBC from the nadir to 20,000mm3 OR an absolute increase in WBC by 50,000mm3 above the lowest count after starting imatinib mesylate 